Delivra Health Brands Inc.
DHBUF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $13,370 | $12,378 | $9,791 | $8,139 |
| % Growth | 8% | 26.4% | 20.3% | – |
| Cost of Goods Sold | $6,592 | $5,979 | $4,968 | $5,535 |
| Gross Profit | $6,778 | $6,399 | $4,823 | $2,604 |
| % Margin | 50.7% | 51.7% | 49.3% | 32% |
| R&D Expenses | $0 | $0 | $0 | $352 |
| G&A Expenses | $4,115 | $4,251 | $4,081 | $4,894 |
| SG&A Expenses | $6,351 | $5,800 | $4,856 | $6,497 |
| Sales & Mktg Exp. | $1,956 | $1,549 | $775 | $1,603 |
| Other Operating Expenses | $1,268 | $1,309 | $1,330 | $2,165 |
| Operating Expenses | $7,619 | $7,109 | $6,186 | $9,014 |
| Operating Income | -$618 | -$710 | -$1,363 | -$6,410 |
| % Margin | -4.6% | -5.7% | -13.9% | -78.8% |
| Other Income/Exp. Net | -$256 | $1,586 | $1,179 | -$599 |
| Pre-Tax Income | -$874 | $876 | -$184 | -$7,009 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$874 | $876 | -$184 | -$7,009 |
| % Margin | -6.5% | 7.1% | -1.9% | -86.1% |
| EPS | -0.028 | 0.031 | -0.007 | -0.28 |
| % Growth | -191.2% | 520.5% | 97.4% | – |
| EPS Diluted | -0.028 | 0.031 | -0.007 | -0.28 |
| Weighted Avg Shares Out | 31,262 | 28,566 | 25,262 | 25,262 |
| Weighted Avg Shares Out Dil | 31,262 | 28,566 | 25,262 | 25,262 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $87 | $169 | $250 | $635 |
| Depreciation & Amortization | $931 | $1,309 | $1,330 | $2,119 |
| EBITDA | $144 | $2,354 | $1,396 | -$4,255 |
| % Margin | 1.1% | 19% | 14.3% | -52.3% |